Altered MUC1 epitope‐specific CTLs: A potential target for immunotherapy of pancreatic cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Altered MUC1 epitope‐specific CTLs: A potential target for immunotherapy of pancreatic cancer
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-10-12
DOI
10.1002/jlb.5ma0922-749r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity
- (2021) Georgios Sogkas et al. Cellular & Molecular Immunology
- MUC1: Structure, Function, and Clinic Application in Epithelial Cancers
- (2021) Wenqing Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pancreatic cancer: A review of epidemiology, trend, and risk factors
- (2021) Jian-Xiong Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
- (2021) Rosmely Hernandez et al. Journal for ImmunoTherapy of Cancer
- Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
- (2021) Jie Cai et al. CANCER LETTERS
- Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy
- (2021) Dong-Hee Lee et al. Pharmaceuticals
- An altered HLA-A0201-restricted MUC1 epitope that could induce more efficient anti-tumor effects against gastric cancer
- (2020) Huahui Yu et al. EXPERIMENTAL CELL RESEARCH
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy
- (2020) Shunda Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pancreatic cancer
- (2020) Jonathan D Mizrahi et al. LANCET
- T-Cell Immunity in Pancreatic Cancer
- (2020) Reham Ajina et al. PANCREAS
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer
- (2019) Dinh-Toi Chu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- Emerging trends in the immunotherapy of pancreatic cancer
- (2018) Kasturi Banerjee et al. CANCER LETTERS
- A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
- (2018) Xuexiang Du et al. CELL RESEARCH
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Evolutionary Pressure against MHC Class II Binding Cancer Mutations
- (2018) Rachel Marty et al. CELL
- CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
- (2018) Bagher Farhood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- High-throughput determination of the antigen specificities of T cell receptors in single cells
- (2018) Shu-Qi Zhang et al. NATURE BIOTECHNOLOGY
- The Distribution of Activation Markers and Selectins on Peripheral T Lymphocytes in Preeclampsia
- (2017) Anna Bajnok et al. MEDIATORS OF INFLAMMATION
- An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
- (2017) Anne-Mette Bjerregaard et al. Frontiers in Immunology
- T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression
- (2016) Aude G. Chapuis et al. JOURNAL OF CLINICAL ONCOLOGY
- The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
- (2016) Richard Beatson et al. NATURE IMMUNOLOGY
- MUC1-C activates BMI1 in human cancer cells
- (2016) M Hiraki et al. ONCOGENE
- DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells
- (2016) H Rajabi et al. ONCOGENE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
- (2016) Kankana Bardhan et al. Frontiers in Immunology
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Impact of Ficoll density gradient centrifugation on major and trace element concentrations in erythrocytes and blood plasma
- (2015) Ying Lu et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- HLA-A2–Restricted Cytotoxic T Lymphocyte Epitopes from Human Heparanase as Novel Targets for Broad-Spectrum Tumor Immunotherapy
- (2015) Ting Chen et al. NEOPLASIA
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Identification and Enhancement of HLA-A2.1-Restricted CTL Epitopes in a New Human Cancer Antigen-POTE
- (2013) Yi-Hsiang Huang et al. PLoS One
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
- (2012) D W Kufe ONCOGENE
- T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy
- (2011) Laura M. Snell et al. IMMUNOLOGICAL REVIEWS
- Interdisciplinary Analysis of HIV-Specific CD8+ T Cell Responses against Variant Epitopes Reveals Restricted TCR Promiscuity
- (2010) I. Hoof et al. JOURNAL OF IMMUNOLOGY
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
- MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
- (2010) L D Roy et al. ONCOGENE
- CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice
- (2009) Paula Kolar et al. ARTHRITIS AND RHEUMATISM
- Identification and modification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from Ran antigen
- (2009) Fan Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Self-antigen–specific CD8+T cell precursor frequency determines the quality of the antitumor immune response
- (2009) Gabrielle A. Rizzuto et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More